## Abstract ## BACKGROUND. The purpose was to identify the factors predictive of recurrence and survival in patients with highβrisk (stage I, grade 3; stage IC, stage II, or clear cell) epithelial ovarian cancer after adjuvant therapy. ## METHODS. Data was extracted from patients who underwent p
Prognostic factors in well-differentiated early-stage epithelial ovarian cancer
β Scribed by J. A. Schueler; C. J. Cornelisse; J. Hermans; J. B. Trimbos; M. E. L. Van Der Burg; G. J. Fleuren
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 816 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
High levels of plasminogen activator inhibitor-1 (PAI-1) in tissue extracts have been associated with poor prognosis in many epithelial cancers. Ovarian cancers contain a higher concentration of PAI-1 than benign ovarian tumors or normal ovaries. Reports, however, on the prognostic value of PAI-1 co
The expression of specific cell-adhesion molecule CD44 isoforms (splice variants) is associated with metastatic spread and poor prognosis in human malignancies. The aim of this study was to evaluate whether CD44 isoform expression is a prognostic factor in early-stage cervical cancer. We used 4 diff